Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2023 15:13 ET | Quelle: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

NEW YORK, April 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Rollins, Inc....
19. März 2023 13:27 ET | Quelle: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

NEW YORK, March 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Rollins, Inc....
09. März 2023 18:08 ET | Quelle: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Rollins, Inc....
14. Februar 2023 16:49 ET | Quelle: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Rollins, Inc....
06. September 2022 21:08 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating RBC, Intuit, Rollins, and PROG and Encourages Investors to Contact the Firm

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RBC Bearings Incorporated...
15. August 2022 21:00 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Intuit, Rollins, Avaya, and RBC and Encourages Investors to Contact the Firm

NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Intuit, Inc. (NASDAQ:...
11. August 2022 12:18 ET | Quelle: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rollins, Inc. Investors to Inquire About Securities Class Action Investigation – ROL

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Rollins,...
20. Juli 2022 21:00 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm

NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc....
15. Juli 2022 21:00 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm

NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc....
10. Juli 2022 21:00 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Corcept, Rollins, Target, and TG Therapeutics and Encourages Investors to Contact the Firm

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Corcept Therapeutics, Inc....

Nächste Seite